Elsevier BV is a Netherlands company which, according to its website, is a ‘world-leading provider of information solutions’; in other words, it is a publisher. Its main focus is on science and medicine. It publishes 2,900 journals in one format or another, including such well known periodicals as Acta Anaesthesiologica Taiwanica, or the American Journal of Otolaryngology, or the unputdownable Prostaglandins, Leukotrienes & Essential Fatty Acids. It has published more than 24,000 academic books. So one thing you already know about Elsevier is that it holds the key to publication for many academics, and to access to scholarship for university libraries and their readers.
And it is not cheap. So for example, the seminal book Dacie and Lewis Practical Haematology will, should you decide to buy it, set you back €93. And if you think your library should subscribe to Prostaglandins, you may want to let them know that the electronic version (only) will cost €3,743.33; if you need it in print, that’ll be €4,524.
It would not be fair to single out Elsevier; it is merely doing what companies do in an inadequately competitive market. Academic publishing is full of such examples; th0ugh not that full, because the number of really significant publishers is not a large one. And as universities across the worlds try to prioritise their expenditure, library subscriptions and purchases have become more and more unaffordable.
And yet, universities have not seriously resisted the exploitation by publishers, beyond agitated discussions. However, now a German university, the University of Konstanz, has told Elsevier that the university ‘will no longer keep up with this aggressive pricing policy and will not support such an approach’. More precisely, it has decided to discontinue the existing licensing arrangement, and to tell academics that they will instead support them when they need individual access.
Perhaps this bold step will prompt a wider and more decisive response by the global academy. Perhaps it will create more debate about how open access publishing can be developed in such a way that scholarly output is not pulled behind an excessively high paywall. Perhaps the abuse of trade in knowledge in a very imperfect market can be fought after all.